Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eliem Therapeutics Inc (NQ: ELYM )

5.110 UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 5.110
Bid (Size) 4.950 (5)
Ask (Size) 5.300 (10)
Prev. Close 5.110
Today's Range 5.110 - 5.110
52wk Range 2.350 - 11.55
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Eliem Therapeutics Announces Rebranding and Corporate Name Change to Climb Bio, Inc.
From Eliem Therapeutics, Inc.
Via GlobeNewswire
Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit
From Eliem Therapeutics, Inc.
Via GlobeNewswire

Performance

YTD
+82.50%
+82.50%
1 Month
+0.39%
+0.39%
3 Month
-38.36%
-38.36%
6 Month
-32.50%
-32.50%
1 Year
+92.83%
+92.83%

More News

Read More
Build-A-Bear Workshop Posts Upbeat Earnings, Joins Affirm, Nutanix, Cooper Companies, Veeva Systems And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Eliem Therapeutics Announces Additions to its Leadership Team
From Eliem Therapeutics, Inc.
Via GlobeNewswire
ELYM Stock Earnings: Eliem Therapeutics Reported Results for Q2 2024
Via InvestorPlace
Eliem Therapeutics Reports Second Quarter Financial Results
From Eliem Therapeutics, Inc.
Via GlobeNewswire
IQVIA Posts Upbeat Earnings, Joins Terex, Reddit And Other Big Stocks Moving Higher On Monday
Via Benzinga
Eliem Therapeutics Announces its Addition to the Russell 2000® and Russell 3000® Indexes
From Eliem Therapeutics, Inc.
Via GlobeNewswire
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
From Eliem Therapeutics, Inc.
Via GlobeNewswire
ELYM Stock Earnings: Eliem Therapeutics Reported Results for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Nasdaq Jumps 250 Points; Crude Oil Down 1%
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Eliem Therapeutics Shifts From Neurology With New Found Focus On Autoimmune Diseases With Tenet Medicines Deal
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Dow Dips 100 Points; CarMax Earnings Miss Views
Via Benzinga
Topics Earnings Stocks
Exposures Financial US Equities
Nasdaq Gains Over 50 Points; US Producer Prices Increase In March
Via Benzinga
Topics Stocks
Exposures US Equities
ELYM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Eliem Therapeutics, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
From Eliem Therapeutics, Inc.
Via GlobeNewswire
ELYM Stock Earnings: Eliem Therapeutics Reported Results for Q4 2023
Via InvestorPlace
Why Metropolitan Bank Holding Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.